Similar articles for PMID: 31659103

Year	Number of Results
1986	1
1993	1
1997	1
1998	1
2001	1
2002	1
2004	1
2005	4
2006	1
2008	1
2009	1
2010	1
2011	3
2012	5
2013	2
2014	6
2015	9
2016	12
2017	3
2018	8
2019	4
2020	3
2021	1
2022	4
2023	1
2024	0

1

The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.

Hargadon KM, Györffy B, Strong EW, Tarnai BD, Thompson JC, Bushhouse DZ, Johnson CE, Williams CJ. Hargadon KM, et al. Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):491-503. doi: 10.21873/cgp.20152. Cancer Genomics Proteomics. 2019. PMID: 31659103 Free PMC article.

2

Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.

Li C, Ding H, Tian J, Wu L, Wang Y, Xing Y, Chen M. Li C, et al. Cell Physiol Biochem. 2016;39(1):242-52. doi: 10.1159/000445620. Epub 2016 Jun 24. Cell Physiol Biochem. 2016. PMID: 27336949 Free article.

3

The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas.

Hargadon KM, Győrffy B, Strong EW. Hargadon KM, et al. Cancer Genet. 2021 Jun;254-255:58-64. doi: 10.1016/j.cancergen.2021.02.005. Epub 2021 Feb 13. Cancer Genet. 2021. PMID: 33636524

4

FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.

Cai J, Tian AX, Wang QS, Kong PZ, Du X, Li XQ, Feng YM. Cai J, et al. Cancer Lett. 2015 Oct 28;367(2):129-37. doi: 10.1016/j.canlet.2015.07.001. Epub 2015 Jul 22. Cancer Lett. 2015. PMID: 26210254 Free article.

5

Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.

Reu FJ, Bae SI, Cherkassky L, Leaman DW, Lindner D, Beaulieu N, MacLeod AR, Borden EC. Reu FJ, et al. J Clin Oncol. 2006 Aug 10;24(23):3771-9. doi: 10.1200/JCO.2005.03.4074. Epub 2006 Jun 26. J Clin Oncol. 2006. PMID: 16801630

6

FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition.

Zhou Z, Zhang L, Xie B, Wang X, Yang X, Ding N, Zhang J, Liu Q, Tan G, Feng D, Sun LQ. Zhou Z, et al. Cancer Lett. 2015 Jul 28;363(2):137-45. doi: 10.1016/j.canlet.2015.04.008. Epub 2015 Apr 17. Cancer Lett. 2015. PMID: 25896630

7

Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).

Li C, Ding H, Tian J, Wu L, Wang Y, Xing Y, Chen M. Li C, et al. Cell Physiol Biochem. 2016;39(3):1098-110. doi: 10.1159/000447818. Epub 2016 Aug 26. Cell Physiol Biochem. 2016. PMID: 27562816 Free article.

8

FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells.

He Y, Xie H, Yu P, Jiang S, Wei L. He Y, et al. Cancer Chemother Pharmacol. 2018 Dec;82(6):1049-1059. doi: 10.1007/s00280-018-3697-2. Epub 2018 Oct 9. Cancer Chemother Pharmacol. 2018. PMID: 30302523

9

The Foxc2 transcription factor regulates tumor angiogenesis.

Sano H, Leboeuf JP, Novitskiy SV, Seo S, Zaja-Milatovic S, Dikov MM, Kume T. Sano H, et al. Biochem Biophys Res Commun. 2010 Feb 5;392(2):201-6. doi: 10.1016/j.bbrc.2010.01.015. Epub 2010 Jan 12. Biochem Biophys Res Commun. 2010. PMID: 20060810 Free PMC article.

10

Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.

Zhang CL, Zhu KP, Ma XL. Zhang CL, et al. Cancer Lett. 2017 Jun 28;396:66-75. doi: 10.1016/j.canlet.2017.03.018. Epub 2017 Mar 16. Cancer Lett. 2017. PMID: 28323030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year